Evidence map›Paper›PMID 40321008›Full record

ReviewThe Journal of physiology2025

The mysterious middlemen making your vision pop: understanding the function of amacrine cells.

Victor Calbiague-Garcia, Deborah Varro, Thomas Buffet, Olivier Marre

Abstract readReview
In one paragraph

Review in The Journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Victor Calbiague-GarciaInstitut de la Vision, Sorbonne University, CNRS, INSERM, Paris, France.
Deborah VarroInstitut de la Vision, Sorbonne University, CNRS, INSERM, Paris, France.
Thomas BuffetInstitut de la Vision, Sorbonne University, CNRS, INSERM, Paris, France.
Olivier MarreInstitut de la Vision, Sorbonne University, CNRS, INSERM, Paris, France.

Funding

EC | ERC | HORIZON EUROPE European Research Council (ERC) 101045253
6 · The paper itself

Abstract

In many brain regions, inhibitory interneurons represent a highly diverse class of cells, and the specific roles of most subtypes remain unclear. This diversity is particularly striking in the retina, where amacrine cells, the primary inhibitory interneurons, form the most diverse population, with nearly 67 subtypes in mice. Recent methodological advances have provided unprecedented insight into this complexity. Techniques such as transcriptomics, connectomics and targeted electrophysiological recordings have made it possible to isolate and characterize individual amacrine cell types. Here, we review current knowledge of amacrine cells and discuss how emerging approaches are advancing our understanding of their function, with a focus on the mouse retina. Several subtypes can now be genetically targeted, allowing for detailed study of their morphology and light responses. A promising avenue of research is investigating how these cells process complex stimuli and whether their responses vary across different dendritic compartments. Amacrine cells play a fundamental role in visual computations, often through dedicated circuit motifs. However, for most subtypes, their specific contributions to these motifs remain unknown. A key open question is whether different amacrine subtypes function as independent units within distinct circuits or if they are interconnected within a broader, recurrent inhibitory network. Answering this will be essential to understand how amacrine cells contribute to retinal processing fully.

Indexed as

Amacrine CellsVision, OcularAnimalsHumansRetinaphysiologyretinaretinal physiologyvision

Identifiers

PMID40321008
PMCPMC12576312

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.